496 filings
DEFA14A
OPTN
OptiNose Inc
26 Apr 24
Additional proxy soliciting materials
2:20pm
DEF 14A
OPTN
OptiNose Inc
Definitive proxy
26 Apr 24
2:18pm
SC 13G/A
Rosalind Advisors, Inc.
25 Apr 24
OptiNose / Rosalind Advisors ownership change
7:01pm
8-K
OPTN
OptiNose Inc
25 Apr 24
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
7:41am
4
Anthony J Krick
19 Mar 24
OptiNose / Anthony J Krick ownership change
12:46pm
4
ll3198nr
19 Mar 24
OptiNose / Michael F Marino III ownership change
12:45pm
4
pvd1 cmfqo
19 Mar 24
OptiNose / Ramy A Mahmoud ownership change
12:43pm
8-K
wlumf4h1f2 so4b5ihs7
15 Mar 24
XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
3:36pm
8-K
3co6z1tv
14 Mar 24
Entry into a Material Definitive Agreement
4:27pm
8-K
tjm5tzm6
8 Mar 24
Entry into a Material Definitive Agreement
4:10pm
S-8
kal c2a051dtx4fvd6b
7 Mar 24
Registration of securities for employees
4:32pm
8-K
1u9h2vtzwokw80f4
7 Mar 24
Optinose Reports Fourth Quarter and Full Year 2023 Financial Results
7:00am
4
ne5xt28 3v
29 Feb 24
OptiNose / Anthony J Krick ownership change
4:07pm
4
cxqmc3etsx
29 Feb 24
OptiNose / Paul Jr. Spence ownership change
4:06pm
4
nl51k3khfhs7z07jump
29 Feb 24
OptiNose / Michael F Marino III ownership change
4:05pm
4
vlb xq499ldyj9hed
29 Feb 24
OptiNose / Ramy A Mahmoud ownership change
4:04pm
8-K
oix4vjt6n1 cjc3oz
23 Feb 24
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
7:08am
SC 13G/A
kbcx5p
22 Feb 24
OptiNose / Rosalind Advisors ownership change
4:28pm
SC 13G/A
woj8rn0d gaxdtnt3
14 Feb 24
OptiNose / Rosalind Advisors ownership change
8:48pm